Ahmed M, Rahman N. ATM and breast cancer susceptibility. Oncogene. 2006 Sep25;25(43):5906-11. Review.
Bradbury JM, Jackson SP. ATM and ATR. Curr Biol. 2003 Jun 17;13(12):R468.
Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, DebréM, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Cancer risk inheterozygotes for ataxia-telangiectasia. Int J Cancer. 2001 Jul 15;93(2):288-93.
Hall J. The Ataxia-telangiectasia mutated gene and breast cancer: geneexpression profiles and sequence variants. Cancer Lett. 2005 Sep28;227(2):105-14.
Kim JH, Kim H, Lee KY, Choe KH, Ryu JS, Yoon HI, Sung SW, Yoo KY, Hong YC.Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk.Hum Mol Genet. 2006 Apr 1;15(7):1181-6.
Kitagawa R, Kastan MB. The ATM-dependent DNA damage signaling pathway. ColdSpring Harb Symp Quant Biol. 2005;70:99-109. Review.
Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM andATM-dependent signaling pathways. DNA Repair (Amst). 2004 Aug-Sep;3(8-9):889-900.Review.
Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N. ATM signaling andgenomic stability in response to DNA damage. Mutat Res. 2005 Jan6;569(1-2):123-32. Review.
Lavin MF, Kozlov S. DNA damage-induced signalling in ataxia-telangiectasia andrelated syndromes. Radiother Oncol. 2007 Jun;83(3):231-7.Review.
McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep. 2004 Aug;5(8):772-6.Review.
Motoyama N, Naka K. DNA damage tumor suppressor genes and genomic instability.Curr Opin Genet Dev. 2004 Feb;14(1):11-6. Review.
Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P. The role of ATM in breastcancer development. Breast Cancer Res Treat. 2007 Aug;104(2):121-8.
Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B,Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D; Breast CancerSusceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N. ATMmutations that cause ataxia-telangiectasia are breast cancer susceptibilityalleles. Nat Genet. 2006 Aug;38(8):873-5.
Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003 Mar;3(3):155-68. Review.
Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, TaylorM, Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. JNatl Cancer Inst. 2005 Jun 1;97(11):813-22.
Yang J, Yu Y, Hamrick HE, Duerksen-Hughes PJ. ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. Carcinogenesis. 2003Oct;24(10):1571-80.
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?